GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Atossa Therapeutics
Atossa Therapeutics is a biotech company focused on breast cancer treatment. Its stock price is highly volatile, driven by news of its drug clinical trials, which investors are pinning high hopes on.
Share prices of companies in the market segment - Cancer women
Atossa Therapeutics is a biopharmaceutical company focused on developing drugs for the treatment and prevention of breast cancer. We classify it in the "Women's Cancers" sector. The chart below shows the overall dynamics of this important area of women's health.
Broad Market Index - GURU.Markets
Atossa Therapeutics is an oncology company focused on developing drugs for the treatment and prevention of breast cancer. As a key player in women's health, it is included in our GURU.Markets index. The chart below shows the overall market trend. See how Atossa shares compare to sentiment in the biotech sector.
Change in the price of a company, segment, and market as a whole per day
ATOS - Daily change in the company's share price Atossa Therapeutics
For Atossa Therapeutics, a company focused on breast cancer, the daily price change is a measure of the high volatility inherent in biotech. It reflects the market's reaction to research data and is a key parameter in the risk assessment formulas on System.GURU.Markets.
Daily change in the price of a set of shares in a market segment - Cancer women
Atossa Therapeutics, Inc. is an oncology company. This chart demonstrates the extreme volatility of the biotech sector. Comparison with ATOS, a breast cancer-focused company, helps to assess it as a high-risk asset.
Daily change in the price of a broad market stock, index - GURU.Markets
Atossa Therapeutics is a biotech company focused on women's health, particularly breast cancer. Its shares are highly volatile and dependent on clinical trial results. These scientifically based movements are part of the complex picture of the overall stock market.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Atossa Therapeutics
Atossa Therapeutics' year-to-date performance is a story of breast health drug development. Its 12-month market cap is entirely dependent on progress in clinical trials of its lead candidate, (Z)-endoxifen, which is being studied for both the treatment and prevention of breast cancer.
Annual dynamics of market capitalization of the market segment - Cancer women
Atossa Therapeutics, Inc. is a clinical-stage biotech company focused on breast cancer treatment. Its stock price is entirely dependent on clinical trial results. The chart reflects the high risks and potential for breakthroughs in this important area of medicine.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Atossa Therapeutics is a clinical-stage biotech whose fate depends on scientific breakthroughs, not the state of the economy. Its stock price reflects investor hopes for the success of new drug trials. The company's chart exists in a world of its own, where the main events are data releases.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Atossa Therapeutics
Atossa Therapeutics focuses on the treatment and prevention of breast cancer. Its monthly performance is a barometer of its clinical development. Any news about the progress of its lead drug, (Z)-endoxifen, in trials triggers a strong investor reaction, typical for biotech companies with a narrow focus.
Monthly dynamics of market capitalization of the market segment - Cancer women
Atossa Therapeutics is a clinical-stage pharmaceutical company focused on developing treatments and prevention for breast cancer. The chart below shows the overall dynamics of the biotech sector, where oncology, and breast cancer in particular, is attracting the most attention and investment.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Atossa Therapeutics is a biotech company focused on women's health, particularly breast cancer. Its shares are driven by anticipation of clinical trial results. Their price is a bet on the success of specific medical developments, so they move independently of the broader market.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Atossa Therapeutics
The weekly performance of Atossa Therapeutics, a company focused on breast health, reflects progress in cancer treatment and prevention. Its stock price is responding to clinical trial data from its drugs, which could offer new approaches to this common disease.
Weekly dynamics of market capitalization of the market segment - Cancer women
Atossa Therapeutics focuses on developing breast health products, including cancer prevention and treatment. News of clinical trials in this sensitive area generates strong market reactions. This chart helps differentiate investor reactions to Atossa's data from broader trends in the oncology sector.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Atossa Therapeutics is a biotech company. Its shares can be highly volatile and sensitive to research news. This chart will help you understand whether Atossa is living in its own world of clinical trials, or whether the overall market environment and risk appetite in biotech are influencing its stock price.
Market capitalization of the company, segment and market as a whole
ATOS - Market capitalization of the company Atossa Therapeutics
Atossa's market capitalization chart tells the story of a biotech company focused on treating and preventing breast cancer. Its volatile performance reflects the progress of its lead drug in clinical trials. Its trajectory reflects the hopes for a new, more gentle treatment for this common disease.
ATOS - Share of the company's market capitalization Atossa Therapeutics within the market segment - Cancer women
Atossa Therapeutics is a clinical-stage biopharmaceutical company focused on the treatment and prevention of breast cancer. Its market capitalization reflects the potential of its lead drug, (Z)-endoxifen. The chart below shows how the market perceives its potential to create a new standard in women's health.
Market capitalization of the market segment - Cancer women
Atossa Therapeutics is a clinical-stage biotech company focused on women's health, particularly breast cancer. The chart below shows the overall market capitalization of the oncology sector. Its dynamics provide the backdrop against which Atossa develops its drugs, striving to offer new treatments and prevention methods.
Market capitalization of all companies included in a broad market index - GURU.Markets
Atossa Therapeutics is a biopharmaceutical company focused on women's health, particularly the treatment and prevention of breast cancer. Its market cap reflects the promise of new approaches in this important area. Its performance on the overall chart reflects the company's financial commitment to fighting one of the most common types of cancer.
Book value capitalization of the company, segment and market as a whole
ATOS - Book value capitalization of the company Atossa Therapeutics
Atossa Therapeutics' balance sheet represents its capital invested in clinical trials of drugs to reduce the risk of breast cancer and treat it. This is a tangible, scientific foundation focused on women's health. How has this biotech asset changed? The chart below shows its dynamics.
ATOS - Share of the company's book capitalization Atossa Therapeutics within the market segment - Cancer women
Atossa Therapeutics is focused on breast cancer treatment, which requires R&D laboratories. The chart shows the share of these science-intensive tangible assets, reflecting the physical foundation of its work in women's health.
Market segment balance sheet capitalization - Cancer women
Atossa Therapeutics develops drugs for women's health, particularly for the treatment of breast cancer. Its business is science. The book value chart shows how "light" the company's financial base is at the clinical trial stage.
Book value of all companies included in the broad market index - GURU.Markets
Atossa Therapeutics focuses on women's health, particularly breast cancer. Its book value represents its capital for conducting clinical trials of innovative drugs. The chart shows the material foundation that supports the search for new treatments and prevention methods.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Atossa Therapeutics
Atossa's balance sheet is capital. But investors see hope in new breast cancer treatments. The chart shows the "hope multiple": the premium the market is paying for the potential of its drugs, not for its current assets.
Market to book capitalization ratio in a market segment - Cancer women
Atossa Therapeutics is a biopharmaceutical company focused on women's health, particularly breast cancer. Its value depends on the success of its clinical programs. The chart shows investor expectations for its drugs aimed at preventing and treating this disease.
Market to book capitalization ratio for the market as a whole
Atossa Therapeutics focuses on developing breast health products, including potential treatments for cancer and other conditions. The company operates in the critical and sensitive area of women's health. This chart shows the overall market valuation, but how do investors evaluate a biotech company seeking new ways to prevent and treat breast disease?
Debts of the company, segment and market as a whole
ATOS - Company debts Atossa Therapeutics
Atossa Therapeutics, a biotech company focused on women's health, is dedicating its capital to the fight against breast cancer. This chart shows how it is funding the clinical development of its targeted drugs. This is a targeted investment in one of the most pressing challenges in modern oncology.
Market segment debts - Cancer women
Atossa Therapeutics is a biotech company focused on women's health, specifically developing drugs to treat and prevent breast cancer. This chart shows how the company funds its clinical programs aimed at addressing these important medical problems.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Atossa Therapeutics
Atossa Therapeutics is a biopharmaceutical company focused on women's health, particularly breast cancer. This chart shows its reliance on external funding for clinical trials. For investors, this indicates financial risk on the long road to creating a new standard of treatment or prevention.
Market segment debt to market segment book capitalization - Cancer women
Atossa Therapeutics is a biopharmaceutical company focused on women's health, particularly breast cancer. This chart shows the overall debt burden in the oncology sector. It helps understand how the industry finances its expensive clinical trials and how Atossa, with its niche focus, manages its capital.
Debt to book value of all companies in the market
Atossa Therapeutics is focused on developing treatments for breast health, including cancer. It is a clinical-stage biotech company. Its financial model is based on equity. The market's total debt burden chart highlights how the risks and sources of funding for such companies are fundamentally different from those of traditional economies.
P/E of the company, segment and market as a whole
P/E - Atossa Therapeutics
This chart for Atossa Therapeutics, a company focused on women's health, particularly breast cancer, illustrates investor expectations. Its significance stems from the potential of its drugs to prevent and treat this disease. It's a bet on success in clinical trials targeting a huge and important market.
P/E of the market segment - Cancer women
Breast cancer treatment, Atossa's focus, is a huge market. This chart shows the average valuation for biopharmaceutical companies. It helps to understand that Atossa is valued based on the potential of its drugs to treat and prevent this common disease, which requires successful clinical trials.
P/E of the market as a whole
Atossa Therapeutics is a biopharmaceutical company focused on developing treatments and prevention for breast cancer. The company is exploring innovative approaches, such as oral endoxifen. This chart, showing overall risk appetite, allows us to assess how willing investors are to invest in long-term projects aimed at solving one of the leading women's health problems.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Atossa Therapeutics
Atossa Therapeutics is a clinical-stage biotech focused on women's health, specifically the treatment and prevention of breast cancer. This chart reflects investor speculative expectations for its lead drug, endoxifen. The price trend represents an estimate of its potential.
%20P%2FE%20Atossa%20Therapeutics&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Atossa-Therapeutics&v=1772548928482 "Chart of the company's future (projected) P/E Atossa Therapeutics")
Future (projected) P/E of the market segment - Cancer women
Atossa Therapeutics is a biotech company focused on developing breast health products, including cancer treatment and prevention. This chart shows revenue expectations for the oncology sector. It provides insight into how investors view its lead drug, Endoxifen, and its potential in this area.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Cancer%20women&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Cancer-women&v=1772548928509 "Future (projected) P/E graph of the market segment - Cancer women")
Future (projected) P/E of the market as a whole
Atossa Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing drugs for the treatment and prevention of breast cancer. This chart shows investors' risk appetite. For a company working on an important issue in women's health, it reflects the market's willingness to fund long-term, risky research.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772548928519 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Atossa Therapeutics
Atossa Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on women's health, particularly breast cancer. The financial metrics presented here reflect the costs of developing its drugs. The chart illustrates the financial aspects of the search for new treatments and prevention methods for cancer.
Profit of companies in the market segment - Cancer women
Atossa Therapeutics is a clinical-stage biopharmaceutical company focused on the treatment and prevention of breast cancer. Its lead drug, endoxifen, is being developed to reduce breast density. This chart illustrates how a focus on prevention and early-stage treatment can change the paradigm in oncology and impact profitability.
Overall market profit
Atossa Therapeutics is a biotech company focused on breast health, including developing drugs to treat and prevent cancer. Its future depends on the success of its clinical programs. For such companies, strong economics, as reflected in this chart, means better access to the capital needed to conduct expensive research.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Atossa Therapeutics
Atossa Therapeutics is a biopharmaceutical company focused on the treatment and prevention of breast cancer. The earnings forecast in this chart reflects analysts' expectations for the clinical trial results of its drugs.
%20profit%20of%20the%20company%20Atossa%20Therapeutics&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Atossa-Therapeutics&v=1772548928610 "Graph of future (projected) profit of the company Atossa Therapeutics")
Future (predicted) profit of companies in the market segment - Cancer women
Atossa Therapeutics is a clinical-stage biopharmaceutical company focused on the treatment and prevention of breast cancer. Their lead drug is (Z)-endoxifen. This chart shows the revenue forecast for the women's cancer sector, providing context for assessing the potential of Atossa's developments in this socially significant area of oncology.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Cancer%20women&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Cancer-women&v=1772548928655 "Graph of future (predicted) profits of companies in a market segment - Cancer women")
Future (predicted) profit of the market as a whole
Atossa Therapeutics is a biopharmaceutical company focused on women's health, particularly breast cancer. Its success depends on clinical development. This graph, reflecting the overall investment climate, affects the availability of capital for biotech companies funding long-term research.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772548928694 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Atossa Therapeutics
Atossa Therapeutics is a biopharmaceutical company focused on women's health, particularly developing drugs to treat and prevent breast cancer. This chart reflects investor expectations for its developments. The valuation is a bet on the success of its programs in this important area of medicine.
P/S market segment - Cancer women
Atossa Therapeutics is a biopharmaceutical company focused on developing drugs for the treatment of breast diseases, including cancer. This chart shows the industry average market capitalization to revenue ratio. It reflects how investors view Atossa's clinical programs and the potential of its drugs in the large and important women's health market.
P/S of the market as a whole
Atossa Therapeutics is a clinical-stage biopharmaceutical company focused on developing drugs for the treatment and prevention of breast cancer. The company is working on new approaches to women's health. This chart helps understand how the market values companies aiming to solve major medical problems through innovative research.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Atossa Therapeutics
Atossa Therapeutics is a biopharmaceutical company focused on breast cancer treatment. This chart shows its valuation relative to future projected sales. It reflects investor expectations for the success of its clinical development pipeline, particularly Endoxifen.
%20P%2FS%20Atossa%20Therapeutics&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Atossa-Therapeutics&v=1772548928810 "The graph of the company's future (projected) P/S Atossa Therapeutics")
Future (projected) P/S of the market segment - Cancer women
Atossa Therapeutics is a clinical-stage biopharmaceutical company focused on developing drugs for the treatment and prevention of breast cancer. This chart reflects investor expectations for its lead drug (Z)-endoxifen and its potential in the vast women's health market.
%20P%2FS%20market%20segment%20graph%20-%20Cancer%20women&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Cancer-women&v=1772548928834 "Future (projected) P/S market segment graph - Cancer women")
Future (projected) P/S of the market as a whole
Atossa Therapeutics is a biopharmaceutical company focused on breast cancer treatment. Its future depends on the success of its clinical developments. This general expectations chart for ATOS is not a direct driver. The demand for effective cancer treatment is enormous and unaffected by economic cycles. Clinical success will create its own trends.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772548928887 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Atossa Therapeutics
This chart illustrates the financial trajectory of a biotech company. For Atossa Therapeutics, which focuses on the treatment and prevention of breast cancer, it reflects the funds raised from investors to fund clinical trials of its drug candidates.
Sales of companies in the market segment - Cancer women
Atossa Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the treatment and prevention of breast cancer. Its drugs target breast tissue density reduction. This chart shows revenue in oncology. Atossa's success could offer a new approach to cancer prevention in high-risk women.
Overall market sales
Atossa Therapeutics is a biotechnology company focused on developing drugs for the treatment and prevention of breast cancer. Its research is aimed at solving one of the most pressing issues in women's health. The company's success is part of the innovation process in healthcare that is shaping the economy of the future.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Atossa Therapeutics
Atossa Therapeutics is a biopharmaceutical company focused on developing drugs for the treatment and prevention of breast cancer. Future sales projections depend on the results of its clinical trials.
%20sales%20of%20the%20company%20Atossa%20Therapeutics&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Atossa-Therapeutics&v=1772548929085 "Schedule of future (projected) sales of the company Atossa Therapeutics")
Future (projected) sales of companies in the market segment - Cancer women
Atossa Therapeutics, Inc. is a biopharmaceutical company focused on women's health, particularly the treatment and prevention of breast cancer. The forecast for this sector shows high awareness and demand. The graph reflects the significant need for innovative approaches to treating and reducing the risk of this disease.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Cancer%20women&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Cancer-women&v=1772548929088 "Schedule of future (projected) sales of companies in the market segment - Cancer women")
Future (projected) sales of the market as a whole
Atossa Therapeutics is a biopharmaceutical company focused on the treatment and prevention of breast cancer. Its prospects depend entirely on the success of clinical trials. The overall economic situation, reflected in this chart, does not affect the need for treatment but is important for assessing the investment attractiveness and capital availability of biotech companies.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772548929106 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Atossa Therapeutics
Atossa Therapeutics is a biopharmaceutical company focused on developing drugs to treat breast cancer. While in clinical trials, it incurs significant R&D expenditures. This chart shows the company's investment in addressing one of the most pressing women's health issues.
Market segment marginality - Cancer women
Atossa Therapeutics is a biotechnology company focused on developing drugs for the treatment and prevention of breast cancer. Its financial performance reflects its focus on clinical trials. This chart provides an overview of the company's operating model compared to other companies working in women's health and oncology.
Market marginality as a whole
Atossa Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the treatment and prevention of breast cancer. This chart reflects average returns. In contrast, Atossa is a venture capital investment in oncology. The company is not profitable, and its financial performance reflects clinical research expenses.
Employees in the company, segment and market as a whole
Number of employees in the company Atossa Therapeutics
Atossa Therapeutics is a biopharmaceutical company focused on women's health, particularly the treatment and prevention of breast cancer. Its small but experienced team manages its clinical trial program. An increase on this chart would indicate advancement of its lead drug, endoxifen, into later-stage trials.
Share of the company's employees Atossa Therapeutics within the market segment - Cancer women
Atossa Therapeutics is a biopharmaceutical company focused on women's health, specifically developing drugs for the treatment and prevention of breast cancer. This chart illustrates its narrow focus. It reflects the percentage of oncologists and clinical research specialists working exclusively in breast health that Atossa attracts.
Number of employees in the market segment - Cancer women
Atossa Therapeutics is a biopharmaceutical company focused on breast health, including developing cancer treatments and prevention methods. This chart highlights targeted research in women's health. The growth of the clinical team is driven by the advancement of drugs that could offer new options for millions of women.
Number of employees in the market as a whole
Atossa Therapeutics, Inc. is focused on developing drugs to treat breast cancer. Like many biotech companies, their world is clinical trials. The overall economic situation, reflected in this chart, has little impact on their operations. Research success is the only factor that attracts investors and allows them to expand their team.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Atossa Therapeutics (ATOS)
Atossa Therapeutics is a biopharmaceutical company focused on developing treatments and prevention for breast cancer. This chart demonstrates a business focused on solving a major medical problem. Their high market capitalization per employee reflects the market's assessment of the potential of their drugs, not current revenue or headcount.
%20of%20the%20company%20Atossa%20Therapeutics%20(ATOS)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Atossa-Therapeutics-ATOS&v=1772548929204 "Chart of market capitalization per employee (in thousands of dollars) of the company Atossa Therapeutics (ATOS)")
Market capitalization per employee (in thousands of dollars) in the market segment - Cancer women
Atossa Therapeutics focuses on developing drugs to treat breast cancer. It's a highly specialized biotech company. This chart demonstrates the high value the market places on the intellectual contribution of each scientist on the team working to solve one of the most pressing problems in women's health.
%20by%20market%20segment%20-%20Cancer%20women&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Cancer-women&v=1772548929213 "Market capitalization per employee (in thousands of dollars) by market segment - Cancer women")
Market capitalization per employee (in thousands of dollars) for the overall market
Atossa Therapeutics is a biopharmaceutical company focused on women's health, particularly breast cancer. This graph shows the high employee valuation, as developing a new, effective drug in this area could open a huge market.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772548929252 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Atossa Therapeutics (ATOS)
Atossa Therapeutics is a biotech company focused on women's health, specifically the treatment and prevention of breast cancer with its drug Endoxifen. It is an R&D company. This metric is likely negative. It reflects how much the company invests in each employee to advance its candidate through clinical trials.
%20Chart%20Atossa%20Therapeutics%20(ATOS)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Atossa-Therapeutics-ATOS&v=1772548929264 "Company Profit Per Employee (in thousands of dollars) Chart Atossa Therapeutics (ATOS)")
Profit per employee (in thousands of dollars) in the market segment - Cancer women
Atossa Therapeutics (ATOS) is a biotech company focused on women's health, specifically the treatment and prevention of breast cancer. For a clinical-stage company, this schedule is a theoretical benchmark. All of ATOS's current operations are unprofitable and focused on research. Success would mean their team has created a drug that will generate profits above industry standards.
%20in%20the%20market%20segment%20-%20Cancer%20women&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Cancer-women&v=1772548929291 "Chart of profit per employee (in thousands of dollars) in the market segment - Cancer women")
Profit per employee (in thousands of dollars) for the market as a whole
Atossa Therapeutics (ATOS) is a clinical-stage biotech focused on women's health, particularly breast cancer. This chart, showing negative profits, reflects the company's investment in its team of doctors and scientists developing new treatments.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772548929336 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Atossa Therapeutics (ATOS)
Atossa Therapeutics is a biotech company focused on women's health, particularly breast cancer. This chart reflects its clinical-stage status. Zero revenue is normal. This metric demonstrates potential: a successful drug could lead to explosive growth in revenue per employee.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Atossa-Therapeutics-ATOS&v=1772548929435 "Sales chart per company employee Atossa Therapeutics (ATOS)")
Sales per employee in the market segment - Cancer women
Atossa Therapeutics is a biotech company focused on women's health, specifically developing drugs for the treatment and prevention of breast cancer (e.g., Z-endoxifen). At the R&D stage, this metric reflects how effectively their scientific team generates revenue (e.g., from partnerships).
Sales per employee for the market as a whole
Atossa Therapeutics is a clinical-stage biotech company focused on women's health, specifically the treatment and prevention of breast cancer. It's an R&D company. This chart shows revenue per employee. Predictably, it's zero. It's underlined.
Short shares by company, segment and market as a whole
Shares shorted by company Atossa Therapeutics (ATOS)
Atossa Therapeutics is a biotech company focused on women's health, primarily developing drugs for breast cancer (such as Endoxifen). This chart shows bearish bets. Bearish bets may be hesitant about the success of clinical trials or whether the company's drugs will be competitive with existing treatments.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Atossa-Therapeutics-ATOS&v=1772548929692 "Short Shares Chart for the Company Atossa Therapeutics (ATOS)")
Shares shorted by market segment - Cancer women
Atossa Therapeutics is a biotech company focused on women's health, specifically the treatment and prevention of breast cancer. This chart shows overall short positions in the biotech sector. A high chart reflects general market skepticism about the sector, possibly due to fears of research failure.
Shares shorted by the overall market
Atossa (ATOS) is a clinical-stage biotech company. Its survival depends entirely on access to capital markets. When this market pessimism indicator rises, it signals a "venture winter." Investors panic and flee unprofitable biotechs, fearing ATOS will be unable to raise capital.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Atossa Therapeutics (ATOS)
Atossa Therapeutics is a clinical-stage biotech. Its shares are extremely sensitive to trial news. This chart can surge above 70 on positive R&D data. Oversold territory (<30) often reflects research setbacks, funding concerns, or general risk aversion.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Atossa-Therapeutics-ATOS&v=1772548930057 "RSI 14 indicator chart for the company's stock Atossa Therapeutics (ATOS)")
RSI 14 Market Segment - Cancer women
Atossa (ATOS) is a "biotech" company focused on *women's* cancer. They develop *drugs* (Endoxifen) for *treating* breast cancer. The "Cancer" (biotech) sector thrives on news. RSI_14_Seg shows the "temperature" of the *entire* segment. It's vital to understand: is ATOS's growth due to their R&D, or is *the entire* biotech sector "overheated"?
RSI 14 for the overall market
For Atossa Therapeutics, a biotech in R&D, this chart is a lifeline showing capital availability. During periods of market euphoria, investors are willing to "buy the dream" and fund breakthrough but risky research. When the market panics, the cash spigot is turned off, and cash-burning companies face a liquidity crisis.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast ATOS (Atossa Therapeutics)
Atossa Therapeutics is a biotech company focused on women's health, specifically developing drugs for the treatment of breast cancer (Endoxifen). This chart shows the average target price. Analysts' forecasts are based on clinical data for Endoxifen and its potential for cancer prevention and treatment.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-ATOS-Atossa-Therapeutics&v=1772548930149 "A chart showing analyst consensus forecasts for the expected stock price. ATOS (Atossa Therapeutics)")
The difference between the consensus estimate and the actual stock price ATOS (Atossa Therapeutics)
Atossa is a biopharmaceutical company focused on breast health, specifically developing a drug (Endoxiphen) for the treatment and prevention of breast cancer. This chart illustrates the analyst community's opinion on the company's future. It measures the distance between the stock price and the target, reflecting their confidence in the success of the R&D portfolio.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-ATOS-Atossa-Therapeutics&v=1772548930166 "A chart showing the difference between the consensus forecast and the actual stock price. ATOS (Atossa Therapeutics)")
Analyst consensus forecast for stock prices by market segment - Cancer women
Atossa Therapeutics is a biotech company focused exclusively on women's health, specifically breast cancer treatment and prevention. This chart displays analyst expectations for the oncology sector, demonstrating whether experts believe breakthroughs in breast cancer treatment are possible.
Analysts' consensus forecast for the overall market share price
Atossa Therapeutics (ATOS) is a biopharmaceutical company focused exclusively on breast health. They develop drugs to treat and, more importantly, prevent breast cancer. This chart shows the overall risk appetite, reflecting the willingness of investors to fund long-term R&D projects in preventive medicine.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Atossa Therapeutics
Atossa Therapeutics is a biotech company focused on breast health. Their flagship drug (Endoxifen) is being developed both for the treatment of breast cancer and (uniquely) for breast density reduction (to reduce the risk of cancer). This graph is purely an indicator of their R&D. Its dynamics depend entirely on their (very risky) clinical trial data.
AKIMA Market Segment Index - Cancer women
Atossa Therapeutics is a biopharmaceutical company focused on women's health, primarily developing drugs for the treatment of breast cancer and precancerous conditions. This chart shows the average index for the oncology sector. It helps investors assess how Atossa's performance, with its narrow focus, compares to the average.
The AKIM Index for the overall market
Atossa Therapeutics is a biopharmaceutical company developing treatments and prevention methods for breast cancer (Endoxifen). This chart, which reflects the market average, provides a macro backdrop. It helps assess how this speculative story, which often attracts retail investors, compares to overall economic trends in biotech.
